Perfect Medical Health Management Limited (HKG:1830)
Hong Kong · Delayed Price · Currency is HKD 1.210
-0.040 (-3.20%)
At close: Feb 13, 2026
HKG:1830 Cash Flow Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 160.86 | 206.9 | 315.8 | 315.64 | 305.25 | 284.63 |
Depreciation & Amortization | 170.38 | 178.34 | 201.96 | 223.59 | 219.05 | 171.26 |
Loss (Gain) From Sale of Assets | -1.51 | -1.51 | 0.47 | 1.1 | -0.13 | 0.47 |
Loss (Gain) From Sale of Investments | - | - | - | - | 3.05 | -1.42 |
Stock-Based Compensation | 3.44 | 3.44 | 1.3 | 4.24 | 4.58 | 3.12 |
Other Operating Activities | -15.32 | -22.13 | -7.34 | 4.89 | 56.3 | -6.87 |
Change in Accounts Receivable | 34.4 | 34.4 | -13.14 | -34.99 | 63.21 | -3.2 |
Change in Inventory | -7.52 | -7.52 | 2.46 | -3.04 | -3.07 | -1 |
Change in Accounts Payable | -22 | -22 | 10.04 | 17.33 | -34.29 | 6.84 |
Change in Unearned Revenue | -59.35 | -59.35 | 10.28 | 19.06 | -81.83 | 155.09 |
Change in Other Net Operating Assets | 22.3 | 22.3 | -24.72 | 12.74 | -18.21 | -11.06 |
Operating Cash Flow | 285.68 | 332.88 | 497.12 | 560.57 | 513.9 | 597.86 |
Operating Cash Flow Growth | -30.74% | -33.04% | -11.32% | 9.08% | -14.04% | -7.22% |
Capital Expenditures | -34.65 | -34.65 | -58.29 | -29.05 | -144.55 | -78.22 |
Sale of Property, Plant & Equipment | 4.36 | 4.36 | 0.15 | 0.25 | 1.6 | 1.9 |
Investment in Securities | -142.94 | -142.94 | 218.73 | -193.71 | 151.87 | -223.71 |
Other Investing Activities | 255.87 | 1.3 | 1.97 | 1.45 | 1.16 | 1.79 |
Investing Cash Flow | 82.64 | -171.93 | 162.56 | -221.06 | 10.07 | -298.25 |
Long-Term Debt Repaid | - | -107.6 | -121.12 | -135.68 | -137.72 | -109.5 |
Net Debt Issued (Repaid) | -109.55 | -107.6 | -121.12 | -135.68 | -137.72 | -109.5 |
Issuance of Common Stock | - | - | - | 15 | 15 | 14.99 |
Repurchase of Common Stock | - | - | -1.39 | -10.03 | -21.67 | -4.49 |
Common Dividends Paid | -359.27 | -359.27 | -391.93 | -191.79 | -405.48 | -226.25 |
Other Financing Activities | 141.09 | -11.08 | -6.53 | -12.52 | -16.1 | -13.14 |
Financing Cash Flow | -327.74 | -477.95 | -520.97 | -335.02 | -565.97 | -394.41 |
Foreign Exchange Rate Adjustments | -4.38 | -1.33 | -10.51 | -9.89 | -3.17 | 20.98 |
Net Cash Flow | 36.2 | -318.33 | 128.21 | -5.41 | -45.17 | -73.82 |
Free Cash Flow | 251.03 | 298.23 | 438.84 | 531.52 | 369.34 | 519.64 |
Free Cash Flow Growth | -29.13% | -32.04% | -17.44% | 43.91% | -28.92% | -5.16% |
Free Cash Flow Margin | 25.27% | 26.44% | 31.50% | 38.26% | 27.36% | 47.68% |
Free Cash Flow Per Share | 0.20 | 0.24 | 0.35 | 0.43 | 0.30 | 0.45 |
Cash Interest Paid | 9.66 | 11.08 | 11.22 | 12.52 | 16.1 | 13.14 |
Cash Income Tax Paid | 74.31 | 74.31 | 86.36 | 80.06 | 30.23 | 90.63 |
Levered Free Cash Flow | 182.2 | 219.25 | 359.3 | 400.65 | 322.01 | 427.93 |
Unlevered Free Cash Flow | 188.23 | 226.17 | 366.31 | 408.48 | 332.07 | 436.14 |
Change in Working Capital | -32.17 | -32.17 | -15.08 | 11.11 | -74.19 | 146.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.